Delaware Code Title 16 Sec. 4904 – Prescribing or administering of laetrile
(a) No hospital nor health facility may interfere with the physician-patient relationship by restricting or forbidding the use of laetrile (amygdalin, Vitamin B-17) when prescribed or administered by a physician, surgeon, osteopath or other person engaged in the practice of medicine, as that term is defined in § 1702(11) of Title 24 and/or when requested by a patient, unless the substance as prescribed or administered by the physician or medical practitioner is found to be harmful by the Board of Medical Licensure and Discipline in a public hearing which complies with the Freedom of Information Act [Chapter 100 of Title 29].
Terms Used In Delaware Code Title 16 Sec. 4904
- Freedom of Information Act: A federal law that mandates that all the records created and kept by federal agencies in the executive branch of government must be open for public inspection and copying. The only exceptions are those records that fall into one of nine exempted categories listed in the statute. Source: OCC
(b) No physician, surgeon, osteopath or other person engaged in the practice of medicine, as that term is defined in § 1702(11) of Title 24 shall be subject to disciplinary action solely for the prescribing or administering of laetrile (amygdalin, Vitamin B-17) to a patient under the physician’s, surgeon’s, osteopath’s or other person’s care who has requested the substance.
(c) Under this section laetrile shall not be considered a medical drug, but shall be considered a natural food substance.
61 Del. Laws, c. 90, § ?2; 70 Del. Laws, c. 186, § ?1; 75 Del. Laws, c. 141, § ?2; 77 Del. Laws, c. 319, § ?1; 80 Del. Laws, c. 80, § ?2; 81 Del. Laws, c. 340, § 2; 82 Del. Laws, c. 75, § 3; 83 Del. Laws, c. 52, § 5;